Strengthening the Reporting of Pharmacogenetic Studies (STROPS) guideline / 中华流行病学杂志
Chinese Journal of Epidemiology
; (12): 747-754, 2022.
Article
en Zh
| WPRIM
| ID: wpr-935454
Biblioteca responsable:
WPRO
ABSTRACT
Pharmacogenetic studies are designed to investigate the associations between genetic variation and treatment response for a particular drug in terms of both efficacy and adverse events and have high sample size requirements. To improve the quality of pharmacogenetic studies and facilitate the Meta-analyses to investigate statistically significant associations, Strengthening the Reporting of Pharmacogenetic Studies (STROPS) guideline was developed in 2020 based on the Strengthening the Reporting of Genetic Association Studies (STREGA) statement. The objective of this article is to present a brief introduction to the STROPS guideline and an interpretation of the key points in some items with examples for the better understanding and application.
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Estudios de Asociación Genética
/
Informe de Investigación
/
Pruebas de Farmacogenómica
Tipo de estudio:
Guideline
/
Systematic_reviews
Límite:
Humans
Idioma:
Zh
Revista:
Chinese Journal of Epidemiology
Año:
2022
Tipo del documento:
Article